Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis

Transplant Proc. 1995 Feb;27(1):336-7.

Authors

B Charreau¹, A Cassard, L Tesson, B Le Mauff, D Blanchard, D Lublin, J P Soulillou, I Anegon

Affiliation

¹ Institut National de la Santé et de la Recherche Médicale (INSERM U211), Nantes, France.

PMID: 7533404

No abstract available

MeSH terms

Animals
Antigens, CD / analysis
Antigens, CD / biosynthesis*
Antigens, CD / physiology
Aorta
CD55 Antigens
CD59 Antigens
Cell Survival / drug effects
Cell Survival / physiology
Complement Inactivator Proteins / biosynthesis*
Complement Inactivator Proteins / physiology
Complement System Proteins / pharmacology*
Endothelium, Vascular / cytology
Endothelium, Vascular / drug effects
Endothelium, Vascular / metabolism*
Flow Cytometry
Humans
Membrane Glycoproteins / analysis
Membrane Glycoproteins / biosynthesis*
Membrane Glycoproteins / physiology
Rats
Rats, Sprague-Dawley
Recombinant Proteins / analysis
Recombinant Proteins / biosynthesis
Recombinant Proteins / metabolism
Transfection*

Substances

Antigens, CD
CD55 Antigens
CD59 Antigens
Complement Inactivator Proteins
Membrane Glycoproteins
Recombinant Proteins
Complement System Proteins